================================================================================
                                FONAR CORPORATION

Fonar MRI news @ aol . com                               Inventor of MR Scanning
For    Immediate   Release                               An   ISO  9001  Company

Contact:    Daniel  Culver                               110    Marcus     Drive
Director of Communications                               Melville,   N.Y.  11747
Web site:    www.fonar.com                               Tel:    (631)  694-2929
Email:invest2008@fonar.com                               Fax:    (631)  390-1709
================================================================================

              FONAR Reports Fiscal 2008 Year-End Financial Results

MELVILLE,  NEW YORK,  October  6, 2008 - FONAR  Corporation  (NASDAQ-FONR),  The
Inventor of MR  Scanning(TM),  today  announced  its  financial  results for the
fourth quarter and full year of fiscal 2008 which ended June 30, 2008.

The fiscal 2008 net loss  decreased  47.1% to $13.5 million as compared to a net
loss for fiscal Year 2007 of $25.5  million.  The net loss per share  (basic and
diluted) for fiscal 2008 was ($2.76), as compared to a net loss per share (basic
and diluted) of ($5.29) during fiscal 2007.

Revenues increased by 7.1% to $35.6 million for fiscal 2008 as compared to $33.2
million for fiscal  2007.  Service and repair  fees  revenue  showed the largest
change with an  improvement  of 10.2% in fiscal 2008 to $11.0 million from $10.0
million  in fiscal  2007.  The  increase  was due to the  initiation  of service
contract   agreements   from   recent    installations   of   FONAR   UPRIGHT(R)
Multi-Position(TM) MRI units.

In fiscal 2008 the Company reduced  Research and Development  (R&D) and Selling,
General and  Administrative  expenses (SG&A) by an overall 15.4%.  R&D decreased
12.0% from $5.7  million in fiscal 2007 to $5.0  million in fiscal  2008,  while
SG&A declined 16.1% from $24.3 million in fiscal 2007 to $20.4 million in fiscal
2008.

Total costs  related to revenues  also  decreased by 6.6% from $26.7  million in
fiscal 2007 to $24.8 million in fiscal 2008.

At June 30, 2008,  total assets were $35.2  million,  total current  assets were
$22.0 million,  total cash and marketable  securities  were $2.4 million,  total
current  liabilities  were $38.0 million,  and total long-term  liabilities were
$1.4 million.

FONAR has  scheduled an annual  meeting on November 17, 2008 for the current and
previous  year. On July 8, 2008,  the Company  received a letter from The NASDAQ
Stock Market,  LLC,  indicating it was not in compliance with Marketplace  Rules
4350(e) and 4350(g) due to the fact that it had not  solicited  proxies and held
its annual  meeting  required  to be held  during the fiscal year ended June 30,
2008. As a result,  the notice indicated that the Company's  securities would be
subject to delisting from The NASDAQ Stock Market unless the Company requested a
hearing  before a NASDAQ  Listing  Qualifications  Panel.  On July 15, 2008, the
Company requested a hearing with the NASDAQ Listing  Qualifications  Panel which
was  subsequently  held on August 28,  2008 with no  decision  rendered.  In the
interim, the Company continues to trade on The NASDAQ Stock Market.

Since the introduction of the FONAR UPRIGHT(R)  Multi-  Position(TM) MRI in 2001
and as of June 30, 2008, the Company had sold 162 UPRIGHT(R)  Multi-Position(TM)
MRIs and installed 128. As of June 30, 2008, the backlog is at $36.5 million.

During fiscal 2008, FONAR opened up two new international markets with its first
sales of the FONAR  UPRIGHT(R)  Multi-Position(TM)  MRI to the nations of Canada
and Australia.

A landmark  independent study by the UCLA School of Medicine was reported during
the past  year.  In the  Proceedings  of the 22nd  Annual  Meeting  of the North
American Spine Society (NASS) [The Spine Journal 7 (2007)  1S-163S,  October 23-
27, 2007,  Austin,  Texas],  the  University of  California,  Los Angeles (UCLA)
School of Medicine  presented four scientific papers comparing the visualization
of spine pathology by Dynamic(TM) MRI to images obtained by Static MRI.  Studies
were performed utilizing the FONAR UPRIGHT(R) Multi- Position(TM) MRI scanner in
conjunction with the image analysis software developed by True MRI for the FONAR
UPRIGHT(R) MRI. The software provides comprehensive  "quantitative measurements"
of spinal structures in both the Dynamic(TM) and static positions.

The key findings of the UCLA study were: The "Miss Rate" of spinal  dislocations
(spondylolistheses)  by static only MRI without flexion and extension imaging at
the critical  L4-5 segment was 35.1%;  The "Miss Rate" by static only MRI at the
L3-4 segment was even higher at 38.7%; The overall static MRI "Miss Rate" in the
absence of flexion and extension was 18.1%.

In May 2008,  at the Annual  Meeting of the American  College of Spine  Surgeons
(ACSS)  held  in  California,   attendees  heard  Jeffrey  Wang,  M.D.,   chief,
orthopaedic spine service,  UCLA Comprehensive Spine Center, the lead researcher
from the UCLA School of Medicine studies, speak about the research.

In the Journal of Neurosurgery:  Spine,  December 2007, Volume 7 a peer-reviewed
paper was  published  that  demonstrated  the  value of  UPRIGHT(R)  imaging  in
evaluating the extent of brain  hypermobility in Chiari  malformation  patients.
The  study  was  performed  by  physicians  from  The  Chiari  Institute,  North
Shore-Long Island Jewish Health Systems.

Commenting  on the 2008 fiscal year  results,  Raymond  Damadian,  president and
chairman  of FONAR  said,  "During the first six months of fiscal 2008 we had an
ample amount of sales activity for our FONAR UPRIGHT(R) Multi- Position(TM) MRI.
However,  except for international  activity,  it diminished somewhat during the
second half of the fiscal year. It appears that this was the case throughout the
MRI industry in the United States in general and appeared to be the  consequence
of  the  shortage  of  available  credit  from  the  current  nationwide  credit
insufficiency.  We believe  this will  result in a pent-up  demand for the FONAR
UPRIGHT(R) Multi-Position(TM) MRI."

Dr.  Damadian  continued,  "In recent months we have stepped up a program to cut
costs and expect this to have its impact felt during the first fiscal quarter of
2009. Most  importantly,  besides marketing  UPRIGHT(R) Multi-  Position(TM) MRI
scanners to system  purchasers,  we have  enhanced our  marketing  activities to
consumers  burdened by back pain,  informing them of the importance of obtaining
UPRIGHT(R)  Multi-Position(TM)  MRI  analysis of their backs before any surgical
intervention is contemplated."


                 CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

                                           For the Years ended
                                    --------------------------------
                                    June 30, 2008      June 30, 2007
                                    -------------      -------------
          Revenues                  $ 35,568,833       $ 33,211,932
          Net Income (Loss)         $(13,508,367)      $(25,538,867)
          Basic & Diluted Earnings
          (Loss) per Share             $(2.76)          $(5.29)

________________________________________________________________________________

The Inventor of MR Scanning(TM),  Full Range of Motion(TM),  True Flow(TM),  The
Proof  is  in  the  Picture(TM),   Dynamic(TM),   pMRI(TM),   Multi-Position(TM)
Spondylography(TM)  and  Spondylometry(TM)  are  trademarks,  and UPRIGHT(R) and
STAND-UP(R) are registered trademarks of FONAR Corporation.

            Be sure to visit FONAR's Website for product and investor
                           information: www.fonar.com
                                       ###

This release may include forward-looking statements from the company that may or
may not materialize.  Additional  information on factors that could  potentially
affect the company's  financial results may be found in the company filings with
the Securities and Exchange Commission.

                             ###